Perrigo Company plc (PRGO) Reports $1.06B Q2 Sales, Advances 'Three-S' Strategy

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Perrigo Company plc is one of them.

Perrigo Company plc (NYSE:PRGO), a global leader in consumer self-care products, is sharpening its focus on high-growth, high-margin categories across North America and Europe, and it stands thirteenth on our list among the most oversold stocks. Its portfolio spans pain and sleep aids, nutrition, digestive health, and oral care, with recent gains in OTC store brands signaling competitive strength despite challenging market conditions.

In Q2 2025, Perrigo Company plc (NYSE:PRGO) reported net sales of $1.06 billion, a 0.9% decline year-over-year, influenced by divestitures and exited products, particularly in infant formula and digestive health. The corporation continues to navigate soft seasonal demand in allergy, sun care, and blister care categories, as well as slower-than-expected recovery in infant formula.

Under its “Three-S” strategy—Stabilize, Streamline, and Strengthen- the firm is divesting non-core assets, including the Dermacosmetics business, expected to close in Q1 2026. This move aims to streamline operations, reinforce the balance sheet, accelerate debt reduction, and enable greater focus on its core self-care portfolio.

Operational enhancements, including a global operating model upgrade and strengthened brand-building capabilities, are already contributing to market share gains in key segments. Perrigo Company plc (NYSE:PRGO) is emphasizing innovation and expansion in pain and sleep aids, nutrition, and upper respiratory products, aligning resources with higher-growth categories.

While we acknowledge the potential of PRGO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.